BioMarin Pharmaceutical | BMRN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Bayer 4.14 0.74 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Gilead Sciences 13.51 4.2 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 20.87 5.12 2026-03
Sarepta Therapeutics 27.27 0 2026-03
United Therapeutics 19.15 1.27 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06